David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Pediatrix Medical
MD
$2.16B
| $33.9M | 0.02% |
2,021,337
+443,575
| +28% | +$6.65M |
|
802
Liquidia Corp
LQDA
$6.29B
| $33.8M | 0.02% |
1,487,901
+1,341,462
| +916% | +$29.1M |
|
803
PUT
Bristol-Myers Squibb
BMY
$137B
| $33.8M | 0.02% |
749,000
+150,500
| +25% | +$7.03M |
|
804
KraneShares CSI China Internet ETF
KWEB
$5.18B
| $33.8M | 0.02% |
803,482
-1,532,949
| -66% | -$57.5M |
|
805
Monster Beverage
MNST
$95.8B
| $33.7M | 0.02% |
1,001,308
-1,037,546
| -51% | -$32.4M |
|
806
Prestige Consumer Healthcare
PBH
$2.46B
| $33.6M | 0.02% |
538,025
+251,417
| +88% | +$17.5M |
|
807
UBS Group
UBS
$164B
| $33.6M | 0.02% |
818,817
+420,468
| +106% | +$16.3M |
|
808
CALL
Cameco
CCJ
$44.5B
| $33.5M | 0.02% |
399,900
+316,000
| +377% | +$24.5M |
|
809
PUT
Celsius Holdings
CELH
$8.86B
| $33.5M | 0.02% |
582,200
+20,700
| +4% | +$1.08M |
|
810
CALL
Vale
VALE
$64B
| $33.5M | 0.02% |
+3,081,500
| New | +$31.5M |
|
811
Repligen
RGEN
$10.2B
| $33.4M | 0.02% |
249,930
+244,298
| +4,338% | +$29.7M |
|
812
West Pharmaceutical
WST
$24.9B
| $33.4M | 0.02% |
127,146
-157,190
| -55% | -$38.2M |
|
813
CALL
Telus
TU
$15.5B
| $33.3M | 0.02% |
2,117,300
+992,300
| +88% | +$16.1M |
|
814
Acadia Pharmaceuticals
ACAD
$5.11B
| $33.3M | 0.02% |
1,561,161
-403,360
| -21% | -$9.54M |
|
815
PUT
Okta
OKTA
$22.8B
| $33.3M | 0.02% |
363,300
+187,700
| +107% | +$17.5M |
|
816
WisdomTree
WT
$3.61B
| $33.3M | 0.02% |
2,392,924
+1,795,580
| +301% | +$24M |
|
|
APO.PRA
817
DELISTED
Apollo Global Management Series A
APO.PRA
| $33.1M | 0.02% |
470,000
-50,000
| -10% | -$3.72M |
|
818
CALL
Chipotle Mexican Grill
CMG
$48.1B
| $33M | 0.02% |
841,700
+15,100
| +2% | +$680K |
|
819
Myriad Genetics
MYGN
$292M
| $33M | 0.02% |
4,559,136
+47,639
| +1% | +$283K |
|
820
Goldman Sachs
GS
$302B
| $32.9M | 0.02% |
41,311
+17,054
| +70% | +$12.6M |
|
821
Carter's
CRI
$1.26B
| $32.9M | 0.02% |
1,164,649
-539,322
| -32% | -$15.5M |
|
822
Burlington
BURL
$20.8B
| $32.6M | 0.02% |
128,069
+23,222
| +22% | +$6.31M |
|
|
BNY
823
Bank of New York Mellon
BNY
$110B
| $32.5M | 0.02% |
297,869
-57,987
| -16% | -$5.91M |
|
824
MarketAxess Holdings
MKTX
$5.72B
| $32.3M | 0.02% |
185,618
+16,720
| +10% | +$3.27M |
|
825
CALL
Duolingo
DUOL
$6.87B
| $32.2M | 0.02% |
100,000
+34,100
| +52% | +$11.4M |
|
Similar funds
David Shaw's Q3 2025 Portfolio in Review
As of Q3 2025, David Shaw held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- David Shaw's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- David Shaw added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- David Shaw's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- David Shaw fully exited Hess in Q3 2025, selling an estimated $527M.
- David Shaw's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- David Shaw opened 714 new positions and closed 514 in Q3 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.